Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

69.99
+0.60000.86%
Volume:766.60K
Turnover:53.55M
Market Cap:9.73B
PE:-9.74
High:71.05
Open:70.64
Low:68.92
Close:69.39
52wk High:88.31
52wk Low:47.22
Shares:139.02M
Float Shares:138.02M
Volume Ratio:0.45
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-56.09
PE(LYR):-10.70

Loading ...

Edgewise Therapeutics' Update for EDG-7500 Could Boost Shares, RBC Says

MT Newswires Live
·
May 09

Stock Track | Cytokinetics Soars 5.64% Intraday on Successful $805 Million Public Offering and Positive Clinical Trial Data

Stock Track
·
May 09

Cytokinetics prices 11,338,028-share follow-on offering at $71, raising $805 million

Reuters
·
May 08

Press Release: Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $805 Million

Dow Jones
·
May 08

BUZZ-U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise

Reuters
·
May 08

Cytokinetics Inc : Jefferies Raises Target Price to $105 From $90

THOMSON REUTERS
·
May 07

BUZZ-U.S. STOCKS ON THE MOVE-Catalyst Pharma, DoorDash, Tapestry

Reuters
·
May 07

Cytokinetics (CYTK) Gets a Buy from Wells Fargo

TIPRANKS
·
May 07

Cytokinetics price target raised to $119 from $101 at RBC Capital

TIPRANKS
·
May 07

Cytokinetics price target raised to $103 from $90 at Morgan Stanley

TIPRANKS
·
May 07

BRIEF-Cytokinetics Prices Public Offering Of 9.8 Mln Shares At $71/Share

Reuters
·
May 07

Cytokinetics prices upsized follow-on offering of 9,859,155 shares at $71 each

Reuters
·
May 07

Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock

THOMSON REUTERS
·
May 07

Cytokinetics Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
May 07

Cytokinetics' Rapid Growth of Myqorzo not Fully Priced in by Investors, RBC Says

MT Newswires Live
·
May 07

BUZZ-Cytokinetics slides on stock sale plans following heart disease study

Reuters
·
May 07

RBC Adds Speculative Risk to Outperform Rating on Cytokinetics, Lifts Price Target to $119 From $101

MT Newswires Live
·
May 06

Cytokinetics Inc : RBC Raises Target Price to $119 From $101

THOMSON REUTERS
·
May 06

Cytokinetics Inc : Needham Raises Target Price to $102 From $85

THOMSON REUTERS
·
May 06

Cytokinetics Earnings Call Highlights Launch, Trial Wins

TIPRANKS
·
May 06